openPR Logo
Press release

Early-Stage Lung Cancer Diagnostics Therapy Market 2018 - 2028 By Top Players | Quest Diagnostics Incorporated, NanoString Technologies. Inc, NeoGenomics Laboratories

01-15-2019 09:16 AM CET | Health & Medicine

Press release from: Future Market Insights

Early-Stage Lung Cancer Diagnostics Therapy Market 2018 - 2028

Cancer is the second most active disease in the world currently by the no. of deaths it is responsible for. Today’s complex time has issued an alarming situation for the consumers as well as the manufacturers to limit the cases with early diagnosis on every term. Early-stage lung cancer diagnostics therapy is performed to diagnose the presence of cancer cells in lungs with immediate care offered. Cancer was a leading cause of death worldwide. According to the National Cancer Institute at the National Institutes of Health, around 8.2 million cancer deaths and 14 million new cases were registered in 2012. The need for a well-organized early-stage lung cancer diagnostics therapy in is due to the fact that only 18% of the lung cancer cases get recognized while the remaining undiagnosed cancer cases progress into more hostile forms of cancer cells, which reduces the survival rate to only few percent’s in patients that are diagnosed with late-stage lung cancer.

Early-Stage Lung Cancer Diagnostics Therapy Market: Drivers and Restraints

Often the fact is ignored that the patients are prime responsible in order to run a business as crucial as early-stage lung cancer diagnostics therapy. Where the first push to enter an early-stage lung cancer diagnostics therapy is dependent on the subject (patient) as the call for early detection by identifying few symptoms is his/her take. Also due to lack of resources and a rising middle class population the diagnosis can be delayed by months or even years in cases and few companies and government initiatives are taking advantage to clear that cloud. Early-stage lung cancer diagnostics therapy is the first line of treatment which starts from diagnosis of present cancer cells, it would significantly decrease global cancer mortality by diagnosing at a remediable stage. Early-stage lung cancer diagnostics therapy involves the advancement of lung cancer-specific biomarkers which is also termed to be an early-stage lung cancer diagnostics therapy is one of the key factors for the development of the early-stage lung cancer diagnostics therapy market over the forecast period. These early-stage lung cancer diagnostics therapy ease the modified treatment method of lung malignancies. The market for early-stage lung cancer diagnostics therapy is restricted regarding their use, low healthcare expenditure in developing regions, costs considerations, etc.

Request to View a Sample Copy of This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7843

Early-Stage Lung Cancer Diagnostics Therapy Market: Segmentation

Tentatively, the global Early-Stage Lung Cancer Diagnostics Therapy Market has been segmented on the basis of cell type, test type, end user and geography.

Based on cell type, the global Early-Stage Lung Cancer Diagnostics Therapy Market is segmented as:

Non Small-cell Lung Cancer

Small-cell Lung Cancer

Based on test type, the global Early-Stage Lung Cancer Diagnostics Therapy Market is segmented as

EGFR test

CA test

BRAF test

ALK test

ROS1 test

HER2 test

RET test

Others

Based on end user, the global Early-Stage Lung Cancer Diagnostics Therapy Market is segmented as:

Cancer research laboratories

Hospital associated laboratories

Independent cancer diagnostic laboratories

Early-Stage Lung Cancer Diagnostics Therapy Market: Overview

The global market early-stage lung cancer diagnostics therapy is consolidated with several players operating in the global space. Combined approaches of using early-stage lung cancer diagnostics therapy with better technological advancements to omit the undue problems while performing the diagnosis procedure. Some of the established companies for early-stage lung cancer diagnostics therapy are Abbott Laboratories, Danaher Corporation, Thermo Fischer Scientific, Inc.and Roche Holding AG.

Early-Stage Lung Cancer Diagnostics Therapy Market: Regional Wise Outlook

Geographically, the Early-Stage Lung Cancer Diagnostics Therapy Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding China and Japan, Japan, China, Middle East and Africa. The North America account for a significant market share owing to extensive use of medication and cancer programs being initiated. Additionally, the fastest uptake of new methods in the US drives the early-stage lung cancer diagnostics therapy market. Western Europe is the second largest market in the world due to high income and healthcare penetration. Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period for early-stage lung cancer diagnostics therapy market. Gulf nations such as Saudi Arabia and the UAE are projected to drive the Middle East & African market, moderate growth is expected owing to poor economic and healthcare development. China is expected to take a progressive step in the market for global early-stage lung cancer diagnostics therapy market throughout the forecast period due to its reformed healthcare policies and public initiatives to cut down the prevalence rate.

Demographic change in respective countries show different landscape for early-stage lung cancer diagnostics therapy, with the volume of such procedures is more in developed countries as compare to countries in Latin America and Africa.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/toc/rep-gb-7843

Early-Stage Lung Cancer Diagnostics Therapy Market: Key Players

Examples of some of the major players in the global Early-Stage Lung Cancer Diagnostics Therapy Market are Abbott Laboratories, Danaher Corporation, Thermo Fischer Scientific, Inc., QIAGEN N.V., Illumina, Inc., Quest Diagnostics Incorporated, NanoString Technologies. Inc, NeoGenomics Laboratories, Inc., Myriad Genetics, Inc. and Roche Holding AG. are some of the key players operating in this market. Technological advancements in biomarkers is the major trend emerging in the global early-stage lung cancer diagnostics therapy market.

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Early-Stage Lung Cancer Diagnostics Therapy Market 2018 - 2028 By Top Players | Quest Diagnostics Incorporated, NanoString Technologies. Inc, NeoGenomics Laboratories here

News-ID: 1497801 • Views: 468

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and